China Autoimmune Hemolytic Anemia (AIHA) Therapeutics Market


  • Type: Rare Disease Area
  • Published : April 2021
  • Region: Asia
  • Country: China
  • Report ID : 1577

  • Format: PPT, PDF

China Autoimmune Hemolytic Anemia (AIHA) Therapeutics Market: Segmented by Drug Type (Immunosuppressants, Monoclonal Antibodies and Corticosteroids), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital, Retail and Online Pharmacies)- Size, Share, Growth, Trends, and Forecasts (2019 – 2028)

SKU: 1577 Categories: ,

Report Overview

China Autoimmune Hemolytic Anemia (AIHA) Therapeutics market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Autoimmune Hemolytic Anemia (AIHA) is a rare autoimmune disease characterized by an increased destruction of red blood cells (RBCs) mediated by autoantibodies against autologous RBCs. The China have incidence rate of AIHA in adults is 1 to 3 cases per 100,000 persons. The median age at onset is 52 years.

Market Drivers

China is a growing market for autoimmune hemolytic anemia (AIHA) disease due to improvement in healthcare facilities and approval of new medicines. In addition to this, the emergence of biologics and adoption of novel therapeutics are further pushing the market growth. Other factors that contribute to the growth of the market are increase in China’s incidence rate (1 to 3 cases per 100,000 persons), government initiatives, genetic and environmental factors.

However, some factors restrain the growth of the autoimmune hemolytic anemia (AIHA) market such as high cost of treatment, potential adverse effects of some medicines.

1. China Autoimmune Hemolytic Anemia (AIHA) Therapeutics Market Overview….
A. Market Size
2. Market Growth Drivers………………………………………………………………………
A. Genetic and Environmental Factors
B. Increase in Incidence Rate
C. Emergence of Biologics
D. Development of Novel Therapeutics
3. Types of Autoimmune Hemolytic Anemia (AIHA) ……………………………………..
A. Warm Antibody AIHA
B. Cold Antibody AIHA
C. Mixed Type AIHA
D. Drug Induced AIHA
4. Autoimmune Hemolytic Anemia (AIHA) Therapeutics Market Segmentation….
A. By Drug Type
I. Immunosuppressants
II. Monoclonal Antibodies (mAb)
III. Corticosteroids
B. By Route of Administration
I. Oral
II. Parenteral
C. By Distribution Channels
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
5. Autoimmune Hemolytic Anemia (AIHA) Major Products Market Share……
A. Market Analysis, Insights and Forecast – By Revenue Type
6. Competitive Landscape………………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………………
A. Roche Company Overview, Product & Services, Strategies & Financials
B. Grifols Company Overview, Product & Services, Strategies & Financials
C. Alexion Company Overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………….
A. Policy Changes and Reimbursement Scenario
9. Factors Driving Future Growth……………………………………………………………
A. New Trends and Development of Autoimmune Hemolytic Anemia (AIHA) Therapeutics Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Type:

On the basis of drug type, the China autoimmune hemolytic anemia (AIHA) therapeutics market can be segmented into immunosuppressants, monoclonal antibodies and corticosteroids.

Immunosuppressants such as Cyclosporin A and Cyclophosphamide are used for the treatment. Monoclonal antibodies such as Rituximab is used for the treatment.

Corticosteroids (Prednisone) this segment is anticipated to dominate the market due to increase in the usage of corticosteroids for the treatment of autoimmune hemolytic anemia and glucocorticoids are used as a first line treatment.

By Route of Administration:

On the basis of route of administration, the China autoimmune hemolytic anemia (AIHA) therapeutics market can be segmented into oral and parenteral.

Oral route of administration is most commonly preferred to maintain the water and electrolyte balance, some medications such as corticosteroids and immunosuppressants are also given by oral route.

Parenteral route is used for blood transfusion, plasma exchange and for some drugs which are given during surgery.

By Distribution Channel:

On the basis of distribution channel, the autoimmune hemolytic anemia (AIHA) therapeutics market can be segmented into retail, online and hospital pharmacies. Hospital pharmacies are the key distribution channel during the forecast period (2019-2028 as they have a large patient base compared to other healthcare facilities and they also conduct various clinical trials. Retail and online pharmacies are the second largest distribution channels during the forecast period.


Major Players

Some of the key players in China autoimmune hemolytic anemia (AIHA) therapeutics market are Grifols S.A; F. Hoffmann-La Roche Ltd; Alexion Inc.

Key players are adopting various strategies such as licensing agreement, strategic collaboration and acquisition. For instance, Rigel Pharmaceuticals announced that it had entered into an exclusive license and supply agreement with Kissei Pharmaceutical Co., Ltd. to develop and commercialize TAVALISSE (fostamatinib) in China and other Asia countries.

In January 2019 Grifols Announces Collaboration and License Agreement with Rigel Pharmaceuticals for TAVALISSE (fostamatinib).

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements